Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
American Journal of Public Health
|
September 11, 1992
Trend in suicide rates since fluoxetine introduction
D N Masica, J G Kotsanos, C M Beasley, et al.
The Journal of Clinical Psychiatry
|
February 1, 1994
Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features
G D Tollefson, S L Holman, M E Sayler, et al.
Archives of Physical Medicine and Rehabilitation
|
November 1, 1980
Speech sounds: evaluation of a device for their visual presentation
A R Potvin, K G Foreit, K Lam, et al.
International Psychogeriatrics
|
January 1, 1995
A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group
G D Tollefson, J C Bosomworth, J H Heiligenstein, et al.
Journal of the American Geriatrics Society
|
January 1, 1980
Human neurologic function and the aging process
A R Potvin, K Syndulko, W W Tourtellotte, et al.
Archives of Neurology
|
November 1, 1980
Increased ratio of carbidopa to levodopa in treatment of Parkinson's disease
W W Tourtellotte, K Syndulko, A R Potvin, et al.
The Journal of Clinical Psychiatry
|
August 1, 1993
Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reduction
D J Goldstein, A H Rampey, J H Potvin, et al.
Neuroepidemiology
|
January 1, 1996
Analysis of mortality in pergolide-treated patients with Parkinson's disease
M E Sayler, J S Street, J C Bosomworth, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 1, 1995
Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group
D J Goldstein, M G Wilson, V L Thompson, et al.
Journal of Clinical Psychopharmacology
|
June 1, 1994
Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression
G D Tollefson, A H Rampey, C M Beasley, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
American Journal of Public Health
|
September 11, 1992
Trend in suicide rates since fluoxetine introduction
D N Masica, J G Kotsanos, C M Beasley, et al.
The Journal of Clinical Psychiatry
|
February 1, 1994
Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features
G D Tollefson, S L Holman, M E Sayler, et al.
Archives of Physical Medicine and Rehabilitation
|
November 1, 1980
Speech sounds: evaluation of a device for their visual presentation
A R Potvin, K G Foreit, K Lam, et al.
International Psychogeriatrics
|
January 1, 1995
A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group
G D Tollefson, J C Bosomworth, J H Heiligenstein, et al.
Journal of the American Geriatrics Society
|
January 1, 1980
Human neurologic function and the aging process
A R Potvin, K Syndulko, W W Tourtellotte, et al.
Archives of Neurology
|
November 1, 1980
Increased ratio of carbidopa to levodopa in treatment of Parkinson's disease
W W Tourtellotte, K Syndulko, A R Potvin, et al.
The Journal of Clinical Psychiatry
|
August 1, 1993
Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reduction
D J Goldstein, A H Rampey, J H Potvin, et al.
Neuroepidemiology
|
January 1, 1996
Analysis of mortality in pergolide-treated patients with Parkinson's disease
M E Sayler, J S Street, J C Bosomworth, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 1, 1995
Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group
D J Goldstein, M G Wilson, V L Thompson, et al.
Journal of Clinical Psychopharmacology
|
June 1, 1994
Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression
G D Tollefson, A H Rampey, C M Beasley, et al.
Page
of 4